The tumor immune microenvironment correlates with neoadjuvant chemotherapy response in high-grade serous ovarian cancer.

被引:0
|
作者
Zhu, Lei
Cao, Guangming
Hua, Dingchao
Cui, Lina
Zhao, Xiaochen
Wang, Shuzhen
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
[2] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[3] Capital Med Univ, Beijing Chao Yang Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17605
引用
收藏
页码:E17605 / E17605
页数:1
相关论文
共 50 条
  • [1] Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
    Lee, Yong Jae
    Woo, Ha Young
    Kim, Yoo-Na
    Park, Junsik
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Park, Eunhyang
    Joung, Je-Gun
    Lee, Jung-Yun
    CANCERS, 2022, 14 (09)
  • [2] The tumor immune microenvironment modulates response to chemotherapy in high-grade serous epithelial ovarian cancer
    Koti, Madhuri
    Edwards, Andrew
    Squire, Jeremy A.
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Transcriptomic profiles of response to neoadjuvant chemotherapy in patients with high-grade serous ovarian cancer.
    Lee, Sanghoon
    Zhao, Li
    Fleming, Nicole D.
    Celestino, Joseph
    Hajek, Richard A.
    Morgan, Margaret B.
    Liu, Yan
    Westin, Shannon N.
    Jazaeri, Amir A.
    Liu, Jinsong
    Zhang, Jianhua
    Futreal, P. Andrew
    Sood, Anil K.
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Single-cell spatial dynamics of the tumor-immune microenvironment of high-grade serous ovarian cancer during neoadjuvant chemotherapy
    Launonen, Inga-Maria Pauliina
    Szabo, Angela
    Perez, Fernando
    Casado, Julia
    Maliga, Zoltan
    Hautaniemi, Sampsa
    Oikkonen, Jaana
    Hynninen, Johanna
    Vallius, Tuulia
    Nirmal, Ajit Johnson
    Sorger, Peter
    Vaharautio, Anna
    Farkkila, Anniina
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma
    Bohm, Steffen
    Montfort, Anne
    Pearce, Oliver M. T.
    Topping, Joanne
    Chakravarty, Probir
    Everitt, Gemma L. A.
    Clear, Andrew
    McDermott, Jackie R.
    Ennis, Darren
    Dowe, Thomas
    Fitzpatrick, Amanda
    Brockbank, Elly C.
    Lawrence, Alexandra C.
    Jeyarajah, Arjun
    Faruqi, Asma Z.
    McNeish, Iain A.
    Singh, Naveena
    Lockley, Michelle
    Balkwill, Frances R.
    CLINICAL CANCER RESEARCH, 2016, 22 (12) : 3025 - 3036
  • [7] The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy
    van Baal, J. O. A. M.
    Lok, C. A. R.
    Jordanova, E. S.
    Horlings, H.
    van Driel, W. J.
    Amant, F. C.
    Van de Vijver, K. K.
    VIRCHOWS ARCHIV, 2020, 477 (04) : 535 - 544
  • [8] The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy
    J. O. A. M. van Baal
    C. A. R. Lok
    E. S. Jordanova
    H. Horlings
    W. J. van Driel
    F. C. Amant
    K. K. Van de Vijver
    Virchows Archiv, 2020, 477 : 535 - 544
  • [9] Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
    Montgomery, A. M.
    Crossman, D. K.
    Yang, E. S.
    Alvarez, R. D.
    Huh, W. K.
    Bevis, K. S.
    Straughn, J. M., Jr.
    Leath, C. A., III
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 12 - 13
  • [10] Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Arend, Rebecca C.
    Londono, Angelina I.
    Montgomery, Allison M.
    Smith, Haller J.
    Dobbin, Zachary C.
    Katre, Ashwini A.
    Martinez, Alba
    Yang, Eddy S.
    Alvarez, Ronald D.
    Huh, Warner K.
    Bevis, Kerri S.
    Straughn, J. Michael, Jr.
    Estes, Jacob M.
    Novak, Lea
    Crossman, David K.
    Cooper, Sara J.
    Landen, Charles N.
    Leath, Charles A., III
    MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 813 - 824